NASDAQ:CLSD - Clearside Biomedical News Headlines

Sign in or create an account to add this stock to your watchlist.
$1.74 +0.29 (+20.00 %)
(As of 02/21/2019 04:39 AM ET)
Previous Close$1.45
Today's Range$1.61 - $1.90
52-Week Range$0.99 - $15.33
Volume9.16 million shs
Average Volume1.16 million shs
Market Capitalization$55.72 million
P/E Ratio-0.75
Dividend YieldN/A
Beta-1.3

Headlines

Clearside Biomedical (NASDAQ CLSD) News Headlines

Source:
DateHeadline
Clearside Bio up 15% premarket on FDA acceptance of Xipere NDAClearside Bio up 15% premarket on FDA acceptance of Xipere NDA
seekingalpha.com - February 20 at 11:25 AM
Clearside Biomedical’s Suprachoroidal Injection Platform Featured in Multiple Oral Presentations at 42nd Annual Meeting of The Macula SocietyClearside Biomedical’s Suprachoroidal Injection Platform Featured in Multiple Oral Presentations at 42nd Annual Meeting of The Macula Society
finance.yahoo.com - February 19 at 10:38 AM
Healthcare Companies Positioned in Major MarketsHealthcare Companies Positioned in Major Markets
finance.yahoo.com - February 15 at 10:54 AM
Clearside Biomedical Inc (CLSD) Short Interest Up 44.2% in JanuaryClearside Biomedical Inc (CLSD) Short Interest Up 44.2% in January
www.americanbankingnews.com - February 13 at 2:08 AM
Clearside Biomedical Inc (CLSD) Expected to Announce Earnings of -$0.56 Per ShareClearside Biomedical Inc (CLSD) Expected to Announce Earnings of -$0.56 Per Share
www.americanbankingnews.com - February 7 at 9:38 AM
Clearside Biomedical Inc (CLSD) Receives Consensus Recommendation of "Hold" from AnalystsClearside Biomedical Inc (CLSD) Receives Consensus Recommendation of "Hold" from Analysts
www.americanbankingnews.com - February 5 at 3:32 AM
Presentation of Clearside Biomedical’s Extension Study of PEACHTREE for XIPERE™ Exhibits Durability Following Second DosePresentation of Clearside Biomedical’s Extension Study of PEACHTREE for XIPERE™ Exhibits Durability Following Second Dose
finance.yahoo.com - January 20 at 5:12 PM
Clearside Biomedical (CLSD) Presents At 37th Annual J.P. Morgan Healthcare Conference - SlideshowClearside Biomedical (CLSD) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 11 at 5:28 PM
Form SC 13G Clearside Biomedical, Filed by: WHITMORE BRADFORD T - StreetInsider.comForm SC 13G Clearside Biomedical, Filed by: WHITMORE BRADFORD T - StreetInsider.com
www.streetinsider.com - January 5 at 9:23 AM
Clearside Biomedical to Present at the 37th Annual J.P. Morgan Healthcare ConferenceClearside Biomedical to Present at the 37th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 2 at 9:12 AM
Need To Know: Clearside Biomedical, Inc. (NASDAQ:CLSD) Insiders Have Been Buying SharesNeed To Know: Clearside Biomedical, Inc. (NASDAQ:CLSD) Insiders Have Been Buying Shares
finance.yahoo.com - December 21 at 4:45 PM
Clearside Biomedical Submits New Drug Application for XIPERE™ for the Treatment of Macular Edema Associated with UveitisClearside Biomedical Submits New Drug Application for XIPERE™ for the Treatment of Macular Edema Associated with Uveitis
finance.yahoo.com - December 19 at 4:52 PM
Report: Exploring Fundamental Drivers Behind ForeScout Technologies, GNC, Dova Pharmaceuticals, CymaBay Therapeutics, Adesto Technologies, and Clearside Biomedical — New Horizons, Emerging Trends, and Upcoming DevelopmentsReport: Exploring Fundamental Drivers Behind ForeScout Technologies, GNC, Dova Pharmaceuticals, CymaBay Therapeutics, Adesto Technologies, and Clearside Biomedical — New Horizons, Emerging Trends, and Upcoming Developments
finance.yahoo.com - November 27 at 9:49 AM
Clearside Biomedical Inc. (CLSD) CEO Daniel White on Q3 2018 Results - Earnings Call TranscriptClearside Biomedical Inc. (CLSD) CEO Daniel White on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 11 at 9:17 AM
Edited Transcript of CLSD earnings conference call or presentation 8-Nov-18 1:30pm GMTEdited Transcript of CLSD earnings conference call or presentation 8-Nov-18 1:30pm GMT
finance.yahoo.com - November 9 at 9:35 AM
Clearside Biomedical Announces Third Quarter 2018 Financial Results and Provides Corporate UpdateClearside Biomedical Announces Third Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - November 8 at 9:25 AM
Clearside Biomedical to Participate in Stifel 2018 Healthcare ConferenceClearside Biomedical to Participate in Stifel 2018 Healthcare Conference
finance.yahoo.com - November 7 at 4:45 PM
CLSD Loses Shine, AVDLs Q3 Results Disappoint, CWBR Briefly Suspends NASH TrialCLSD Loses Shine, AVDL's Q3 Results Disappoint, CWBR Briefly Suspends NASH Trial
www.nasdaq.com - November 6 at 9:06 AM
Clearside Biomedical Plunges 60% Following Phase 3 Study ResultsClearside Biomedical Plunges 60% Following Phase 3 Study Results
www.benzinga.com - November 6 at 9:06 AM
Clearside Biomedical (CLSD) PT Lowered to $12 at JMP SecuritiesClearside Biomedical (CLSD) PT Lowered to $12 at JMP Securities
www.streetinsider.com - November 5 at 4:47 PM
Why Clearside Biomedical Shares Were HalvedWhy Clearside Biomedical Shares Were Halved
247wallst.com - November 5 at 4:47 PM
Clearside Biomedical to Report Third Quarter 2018 Financial Results on Thursday, November 8, 2018 – Conference Call to FollowClearside Biomedical to Report Third Quarter 2018 Financial Results on Thursday, November 8, 2018 – Conference Call to Follow
finance.yahoo.com - November 5 at 4:47 PM
Clearside Bios Xipere flunks late-stage retinal vein occlusion study; shares down 27% premarketClearside Bio's Xipere flunks late-stage retinal vein occlusion study; shares down 27% premarket
seekingalpha.com - November 5 at 10:38 AM
Clearside Biomedical Announces SAPPHIRE Phase 3 Study of Combination Therapy in Retinal Vein Occlusion Did Not Meet Its Primary EndpointClearside Biomedical Announces SAPPHIRE Phase 3 Study of Combination Therapy in Retinal Vein Occlusion Did Not Meet Its Primary Endpoint
finance.yahoo.com - November 5 at 10:38 AM
Our Take On Clearside BiomedicalOur Take On Clearside Biomedical
seekingalpha.com - October 29 at 4:33 PM
Presentation of Additional Analyses of Clearside’s PEACHTREE Clinical Trial Data Further Supports Potential of XIPERE™ in Treating Uveitic Macular EdemaPresentation of Additional Analyses of Clearside’s PEACHTREE Clinical Trial Data Further Supports Potential of XIPERE™ in Treating Uveitic Macular Edema
finance.yahoo.com - October 29 at 4:33 PM
Clearside Biomedical Appoints Thomas A. Ciulla, M.D., MBA as Chief Medical OfficerClearside Biomedical Appoints Thomas A. Ciulla, M.D., MBA as Chief Medical Officer
finance.yahoo.com - October 25 at 9:10 AM
CLEARSIDE, XIPERE™ and PEACHTREE to be Front and Center at AAO 2018CLEARSIDE, XIPERE™ and PEACHTREE to be Front and Center at AAO 2018
finance.yahoo.com - October 22 at 4:42 PM
Clearside Biomedical Appoints Veteran Supply Chain Executive, Thomas Crawford, as Vice President, Supply ChainClearside Biomedical Appoints Veteran Supply Chain Executive, Thomas Crawford, as Vice President, Supply Chain
finance.yahoo.com - October 19 at 9:12 AM
Detailed Research: Economic Perspectives on Clearside Biomedical, JELD-WEN Holding, LB Foster, Merrimack ...Detailed Research: Economic Perspectives on Clearside Biomedical, JELD-WEN Holding, LB Foster, Merrimack ...
globenewswire.com - October 16 at 4:39 PM
Clearside Biomedical Appoints Jeffrey Edwards to Board of DirectorsClearside Biomedical Appoints Jeffrey Edwards to Board of Directors
finance.yahoo.com - September 26 at 4:34 PM
Alpharetta biopharmaceutical company names GC & chief compliance officerAlpharetta biopharmaceutical company names GC & chief compliance officer
www.bizjournals.com - September 20 at 4:42 PM
Clearside Biomedical (CLSD) Announces Positive PEACHTREE Data to be Highlighted at EURETINA 2018Clearside Biomedical (CLSD) Announces Positive PEACHTREE Data to be Highlighted at EURETINA 2018
www.streetinsider.com - September 19 at 8:40 AM
Positive PEACHTREE Data to be Highlighted at EURETINA 2018Positive PEACHTREE Data to be Highlighted at EURETINA 2018
finance.yahoo.com - September 18 at 4:51 PM
What Investors Should Know About Clearside Biomedical Inc’s (NASDAQ:CLSD) Financial StrengthWhat Investors Should Know About Clearside Biomedical Inc’s (NASDAQ:CLSD) Financial Strength
finance.yahoo.com - September 18 at 4:51 PM
Data From Clearside Biomedical’s Pivotal Phase 3 PEACHTREE Clinical Trial in Macular Edema Associated with Non-Infectious Uveitis to be Presented at the Retina Society 51st Annual Scientific MeetingData From Clearside Biomedical’s Pivotal Phase 3 PEACHTREE Clinical Trial in Macular Edema Associated with Non-Infectious Uveitis to be Presented at the Retina Society 51st Annual Scientific Meeting
finance.yahoo.com - September 13 at 8:43 AM
Clearside Biomedical Appoints Viral Kansara as Vice President, DiscoveryClearside Biomedical Appoints Viral Kansara as Vice President, Discovery
finance.yahoo.com - September 12 at 4:43 PM
Clearside Biomedical Appoints Accomplished Pharmaceutical Industry Legal Executive, Leslie Zacks, as General Counsel and Chief Compliance OfficerClearside Biomedical Appoints Accomplished Pharmaceutical Industry Legal Executive, Leslie Zacks, as General Counsel and Chief Compliance Officer
finance.yahoo.com - September 11 at 4:43 PM
Clearside Biomedical: Buy Or Sell Before 2018 CatalystsClearside Biomedical: Buy Or Sell Before 2018 Catalysts
seekingalpha.com - September 11 at 9:08 AM
Clearside Biomedical to Participate in 2018 Janney Healthcare ConferenceClearside Biomedical to Participate in 2018 Janney Healthcare Conference
finance.yahoo.com - September 10 at 4:36 PM
Clearside Biomedical Further Strengthens Commercial Organization With Appointment of Lester Rodríguez as Vice President, QualityClearside Biomedical Further Strengthens Commercial Organization With Appointment of Lester Rodríguez as Vice President, Quality
finance.yahoo.com - September 6 at 4:48 PM
Clearside Biomedical Inc. (CLSD) CEO Daniel White on Q2 2018 Results - Earnings Call TranscriptClearside Biomedical Inc. (CLSD) CEO Daniel White on Q2 2018 Results - Earnings Call Transcript
seekingalpha.com - August 9 at 9:17 AM
Clearside Biomedical to Participate in 2018 Wedbush PacGrow Healthcare ConferenceClearside Biomedical to Participate in 2018 Wedbush PacGrow Healthcare Conference
finance.yahoo.com - August 9 at 9:17 AM
Clearside Biomedical Announces Second Quarter 2018 Financial Results and Provides Corporate UpdateClearside Biomedical Announces Second Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - August 8 at 9:07 AM
Clearside Biomedical to Report Second Quarter 2018 Financial Results on August 8, 2018 – Conference Call to FollowClearside Biomedical to Report Second Quarter 2018 Financial Results on August 8, 2018 – Conference Call to Follow
finance.yahoo.com - August 1 at 10:45 AM
Laidlaw Starts Clearside Biomedical (CLSD) at BuyLaidlaw Starts Clearside Biomedical (CLSD) at Buy
www.streetinsider.com - July 30 at 4:45 PM
Late-Breaker Oral Presentation on Wednesday, July 25Late-Breaker Oral Presentation on Wednesday, July 25
globenewswire.com - July 17 at 8:32 AM
Clearside Biomedical to Present Data from its Pivotal Phase 3 (“PEACHTREE”) Trial in Macular Edema Associated with Uveitis at the 2018 American Society of Retina Specialists Annual MeetingClearside Biomedical to Present Data from its Pivotal Phase 3 (“PEACHTREE”) Trial in Macular Edema Associated with Uveitis at the 2018 American Society of Retina Specialists Annual Meeting
finance.yahoo.com - July 16 at 4:33 PM
Clearside Biomedical Appoints Carol Hoang as Vice President, Medical AffairsClearside Biomedical Appoints Carol Hoang as Vice President, Medical Affairs
finance.yahoo.com - July 11 at 4:52 PM
Clearside Biomedical: Upside Into Q4 Data And NDA SubmissionClearside Biomedical: Upside Into Q4 Data And NDA Submission
seekingalpha.com - June 17 at 9:16 AM
This page was last updated on 2/21/2019 by MarketBeat.com Staff

Featured Article: Bull Market

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel